RU2000124058ARU2000124058/14ARU2000124058ARU2000124058ARU 2000124058 ARU2000124058 ARU 2000124058ARU 2000124058/14 ARU2000124058/14 ARU 2000124058/14ARU 2000124058 ARU2000124058 ARU 2000124058ARU 2000124058 ARU2000124058 ARU 2000124058A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Волгоградска медицинска академи, Волгоградская медицинская академияfiledCriticalВолгоградска медицинска академи
Priority to RU2000124058/14ApriorityCriticalpatent/RU2263492C2/en
Publication of RU2000124058ApublicationCriticalpatent/RU2000124058A/en
Application grantedgrantedCritical
Publication of RU2263492C2publicationCriticalpatent/RU2263492C2/en
Способ лечения миопии, заключающийся в назначении препарата фенибут, отличающийся тем, что показанием к его применению и контролем эффективности служит вазотонометрия в передних цилиарных артериях.A method of treating myopia, which consists in prescribing the drug phenibut, characterized in that vasotonometry in the anterior ciliary arteries serves as an indication for its use and control of its effectiveness.
RU2000124058/14A2000-09-192000-09-19Method for treating myopia
RU2263492C2
(en)
Use of 2,5-dihydroxybenzenesulfone derivatives for the manufacture of drugs intended for normalization of endothelial function, for the treatment of sexual dysfunction and vascular complications in diabetes, as well as vascular disorders of